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ABSTRACT
SUSAN M. O'TOOLE.  Repair of 0^-Methylguanine and O^'-Methylthymidine in F344
Rat Liver Following Treatment with 1,2-Dimethylhydrazine and O^-Benzylguanine.
(Under The Dkection of Dr. JAMES A. SWENBERG)
Concentrations of O^-methylguanine (O^MG ), C'-methylthymidine (0*MT), and
N7-methylguanine (N-7MG) were measured in the livers of Fischer 344 rats following
treatment with 1,2-dimethylhydrazine (SDMH, 20 mg/kg s.c.) alone or in combination
with the 0*-alkylguanine transferase (AGT) inhibitor, 0^-benzylguanine (O^BG, 100
mg/kg i.p. daily).  Animals were sacrificed at 12, 24, 36, and 48 hours following
SDMH exposure. Direct measurement of AGT demonstrated that O^BG treatment
completely eliminated detectable AGT activity in the livers of treated rats.  Adducts in
liver DNA were quantitated by HPLC separation followed by fluorescence detection,
uv absorption, and/or specific radio immunological assays (RL\).  In animals exposed
to SDMH alone, O^MG and 0'*MT disappeared, whereas animals exposed to both
O^BG and SDMH showed less removal of these adducts, with significant differences
between the two populations appearing at 36 and 48 hours.  O^BG treatment had no
effect on the removal of N-7MG.  These results show that the rate of disappearance of
both O^MG and ©"^MT is slower following AGT depletion and suggest that
mammalian AGT is involved in the removal of O'MT lesions as well as O^MG
lesions.
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INTRODUCTION
Alkylating agents are known carcinogens that are of importance to man because of
environmental exposure to tobacco smoke (Wynder, 1967), dietary exposure to
nitrosoamines (IARC,1978), and their use in cancer chemotherapy.    Alkylation of
DNA and proteins by these agents is both mutagenic and toxic to mammalian cells.
The initial insult is the reaction of the alkylating agent with nucleophilic sites on the
DNA such as the ring nitrogens of guanine and adenine, as well as the oxygens of
DNA (Singer, 1976).  The resulting DNA adducts can lead to mutations, which may
be important in the development of cancer.
O^MG and CMT are both promutagenic lesions, caused by methylation of the O* of
guanine and C* of thymine and can result in GC to AT transitions or AT to GC
transitions if they are not repaired (Loechler 1984, Preston 1986, Ellison 1989).
O^MG is repaired by the transfer of a methyl group from the O^ position to the
sulfhydryl group of a cysteine residue on AGT (Pegg, 1983b)  This can be described
as a suicide mechanism, as the protein cannot be regenerated.  O^MT is repaired by
AGT in bacteria, but the pathway of repair in mammalian cells has not been clearly
identified as being AGT dependent.
AGT has been identified in bacterial, yeast, rodent and human cell types but the
repair activity appears to be different in procaryotes and eukaryotes.  Two AGT
proteins have been identified in E. coli. The ada form is inducible by alkylation and
2has a high affinity for O^MG lesions, while the ogt form is not inducible, has a lower
affinity for O^MG lesions, and a higher affinity for C'MT lesions than ada (Wilkinson
1989, Sassanfar 1991).
In vitro studies have shown that human, monkey, and rat liver extracts repair 0*MT,
although more slowly than O^MG (Becker, 1985).  Recent work with
methyltransferase-proficient (Mer+) and deficient (Mer-) human cell lines, and purified
human AGT have shown that AGT has an affinity for 0*MT, although it is
considerably lower than its affinity for O^MG (Koike 1990, Sassanfar 1991).  Despite
these recent findings, removal of O^MT by mammalian AGT has not been
conclusively shown, and the general consensus from in vivo studies has been that
mammalian AGT does not repair 0*MT (Belinsky 1986, Brent 1988, Hall 1990).  N-
7MG, the major product of methylation, is not subject to active repair by AGT, but is
lost through spontaneous depurination and the activity of DNA-7-methylguanine
glycosylase (Margison, 1981).
In order to study AGT repair, investigators have determined ways to inhibit this
saturable pathway such as creating competition for activity with the alkylated bases
O^MG or O^BG (Dolan, 1990a).  The order of affinity for mammalian AGT is
benzyl>methyl>ethyl>«-propyl>n-butyl>isopropyl>isobutyl  (Pegg 1984, Pegg 1985).
In the bimolecular displacement mechanism of AGT action, O^BG is thought to react
more readily with AGT than other substituents due to its greater ability to take part in
bimolecular reactions (Pegg 1990, Dolan 1990b).  The delocalization of charge in the
transition state by the benzene ring overcomes the steric constraints of the reaction
3(Dolan 1990a). In vivo studies have shown that only O^BG is sufficiently potent to be
an effective inhibitor of AGT repair (Dolan 1990b).
The objective of this study was to determine whether or not the disappearance of
C'MT in vivo is influenced by mammalian AGT.  By inhibiting AGT activity in F344
rats with O^BG, it was possible to look at levels of O^MG and C^MT in animals with
greatly diminished AGT activity.  Our results show that although O^MT removal
occurred more slowly that O^MG repair, both the disappearance of O^MG and C'MT
are influenced by mammalian AGT.
MATERIALS AND METHODS
Animal Exposures. Male F344 (Fischer) rats (180-220 g) were obtained from
Charles River Breeding Laboratories and acclimated for 2-weeks.  Animals were
housed two per cage in polypropylene cages with wood-chip bedding and kept on a
12-hour light-dark cycle.  Food (Agway lab chow) and water were provided ad libitum
throughout the experiment.
O^BG  (kindly provided by Dr. Bob Moschel, Frederick Cancer Research and
Development Center) solutions were prepared fresh daily in 6-ml sterile NaCl (0.85%,
pH 7.4) containing 10% Cremophor EL (Sigma) (5 mg O^BG/ml final concentration).
The batches were incubated at 37°C for 30 minutes (with shaking) and sonicated for
20 minutes prior to injection.  A dose of 100 mg O^BG/kg i.p. was administered daily.
SDMH (Sigma) solutions (12 mg SDMH-2HCl/ml) were prepared fresh daily in 15
pg/ml trisodium EDTA (Mallinckrodt) (pH 6.5, adjusted with IN NaOH).  A single
s.c. injection was administered to deliver 1.7 ml/kg SDMH solution one hour after the
initial O^BG injection.  Control and vehicle control animals accompanied each
timeMose group.
Animals were sacrificed at 12, 24, 36, and 48 hours, using COj asphyxiation. Their
livers, kidneys, and lungs were harvested, frozen in liquid nitrogen, and stored at -
80°C.  Kidney and lung tissue were preserved for possible future analyses.
DNA Isolation.  DNA was isolated and extracted from the liver using an ABI 340A
5Nucleic Acid Extractor with 2 phenol/chloroform (ABI) and 1 chloroform (Fisher)
extractions, followed by precipitation with sodium acetate (ABI) and isopropanol
(Fisher) (Fedtke, 1990).  Purified DNA was stored at 20°C in 4 ml of filtered, distilled
HP (pH 7.0) at-20°C.
HPLC Equipment.  In all HPLC methods described, the equipment consisted of a
Rheodyne 7125 loop injector with a 2 ml loop; two Waters 510 solvent delivery
systems, controlled by a Waters Automated Gradient Controller; an ABI 757 UV
absorbance detector; a Perkin Elmer LS 40 fluorescence detector; a Gilson 203
microfraction collector; and BASELINE software package for peak integration.
Determination of Guanine Concentration.  DNA was sheared by passing it
through a 23 g needle repeatedly to assure homogeneity.  Aliquots of 50-100 pi were
made 0.1 N HCl and incubated at 70°C for 30 minutes to depurinate the sample,
injected by a WISP autosampler (Waters) onto a strong cation exchange HPLC column
(Partisil 10 SCX, 25 x 0.45 cm, Whatman, Inc.), and eluted with 0.1 M ammonium
formate (Fisher), 10% MeOH (Mallinckrodt) buffer at pH 2.8, at a flow rate of 1.5
ml/min (Fedtke, 1990).  Absorbance was measured at 254 nm.
Determination of C^MG. The concentrations of O^MG were quantitated using
HPLC separation coupled with fluorescence detection as previously reported (Bedell,
1982.).  Briefly, 10-75 pg aliquots of DNA were subjected to mild acid hydrolysis and
chromatographed over a strong cation exchange column (Whatman Partisil 10 SCX,
4.6 mm x 25 cm, 5pm), eluted isocratically, using 50 M NH4H2PO4 (Fisher) and 20%
MeOH at pH 2.0 and a flow rate of 1.8 ml/min. The fluorescence of column effluent
6(295 nm excitation, 370 nm emission) was determined.  Under these conditions 1.5
pmols of O^MG was reproducibly integratable, eluting at - 6 minutes.  No O^MG was
detected in control DNA.
Determination of N-7MG. Concentrations of N-7MG were quantitated using
HPLC separation coupled with UV detection, as previously reported (Bedell, 1982).
Briefly, 35-135 pg aliquots of DNA were subjected to neutral thermal hydrolysis,
using 1/10 volume 100 mM C2H7ASO2, (Fisher) (pH 7.0) and heating to 100°C for 30
minutes.  Samples were then acid precipitated using 1/10 volume IN HCl at 4°C for
10 minutes and spinning at 12,000xg for 10 minutes.  The supernatant was
chromatographed over two strong cation exchange columns run in series (Whatman
Partisil 10 SCX, 4.6 mm x 25cm, 5pm), eluted isocratically, using a 75 mM
NH4H2PO4 (Fisher), 12% MeOH buffer at pH 2.0 with a flow rate of 1.5 ml/min.  The
column effluent was quantitated using uv absorption at 250 nm.   10 pmols of N-7MG
was reproducibly integratable, eluting at ~ 15 minutes.  No N-7MG was detected in
control DNA.
Determination of C^MT.  As reported previously (Richardson, 1985.), 1 ml aliquots
containing 2 mg of DNA were digested to nucleosides using DNasel (Sigma),
RNaseTj (Boehringer-Mannheim, Indianapolis,IN), snake venom phosphodiesterase
(Cooper), and bacterial alkaline phosphatase (Sigma).  Normal nucleosides were
quantitated from a 50 pi aliquot on a reverse phase HPLC system (Beckman
Ultrasphere ODS C18 column) using a mobile phase of 88% HPLC H^O, 12% MeOH
at a flow rate of 1.0 ml/min. The uv absorbance was measured at 254 nm.
7The remaining 950 pl/sample (~2 mg DNA) was chromatographed over a reverse
phase HPLC system (Beckman Ultrasphere ODS C18 column, 4.6 mm x 25 cm, 5p)
using a gradient elution (12-22% MeOH 0-10 minutes, 22-35% MeOH from 10-90
minutes with a flow rate of 1.0 ml/min).  UV absorbance (254nm) of the effluent was
monitored.  Twenty fractions of 0.5 min each were collected starting at 18.0 min to
capture the C^MT peak (expected to elute at -22 minutes) and dried under vacuum.
Spiked controls were used to verify the peak by RIA, as the 0'*MT peak was not
visible by uv detection at the levels found in the samples.
Concentrations of C'MT were quantitated using competitive RIA (Farr 1958, MuUer
1980, Richardson 1985).   Briefly, 40 pi of 1% control rabbit sera (Sigma), 4000
dpm/20 pi of tracer ([^H]O^MT, kindly provided by Dr. A. Gold, UNC at Chapel Hill),
and 40 pi of antinucleoside serum diluted to give 50% binding efficiency in controls
(provided by Dr. F. Richardson), were added to each fraction.  Samples were vortexed
and incubated at 37°C with shaking for 15 minutes.   100 pi of saturated (NH4)2S04
(Fisher) was added to precipitate the bound fraction and the samples were incubated at
4°C for 45 minutes.  The samples were centrifuged at 13,600 x g for 15 minutes.
Then 150 pi of the supernatant was pipetted into 10 ml of counting cocktail (Scint-
Verse(BD)) and the samples were counted using a Wallac 1409 Liquid Scintillation
Counter. No O^MT was detected in control DNA.
Determination of AGT activity.  AGT activity was determined in a representative
portion of each liver using the technique as described by Dolan et al. (1990b).
Statistics. Each analyses was run in duplicate for individual animals in each
8time/dose group (n=5).  The mean was determined for each animal and for time/dose
groups from the individual means.  ANOVA tests with t-test p values of 0.05 were
used to analyze the data for significant differences between time/dose groups.
RESULTS
The limits of detection for the HPLC separation of O^MG and N-7MG were 1.5
pmols and 10 pmols respectively (figures la and b).  There was sufficient separation
between the normal nucleosides (especially dT) (figure Ic) and 0*MT in the HPLC
separation that cross-reactivity of the antibody with thymidine was not a problem in
the RIA quantitation of 0'*MT (figure Id).  At 50% inhibition, the limit of detection
for the RIA quantitation of 0*MT was ~ 3.75 pmols after HPLC separation (figure 2).
With hydrolyzed DNA (~2 mg), the assay had a limit of detection of ~ 0.44 pmol
0*MT/umol dT, at -15% inhibition.  The standard curves were consistently linear on a
log-logit transformational plot down to the limit of detection.
AGT activity was greatly diminished through 48 hours in animals receiving daily
doses of O^BG (figure 3a). In the animals that did not receive C'BG, AGT activity
initially declined from control levels following exposure to SDMH to a level almost
undetectable by 12 hours.  However,  AGT activity rose to control levels and above at
36 and 48 hours.
O^MG was removed from DNA during the first 24 hours with an apparent half life
of 12 hours both in animals receiving and not receiving O^BG (figure 3b). The O^MG
adduct concentrations in the two treatment groups were not significantly different at 12
and 24 hours, although the animals that did not receive O^BG had lower
concentrations of O^MG.  However, at 36 and 48 hours, the O^MG concentrations
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were significantly different, with amounts being lower in animals that were not treated
with 0*BG.  No O^MG was detectable in control animals.
In both O^BG treated and untreated animals, no 0*MT removal was demonstrated
until after 24 hours, when AGT activity returned to normal and above normal (figure
3c).  C^MT concentrations remained steady in the animals treated with C'BG through
36 hours.  At 36 and 48 hours, the 0'*MT concentration in animals with and without
O^BG treatment were significantly different.  No 0'*MT was detectable in controls.
N-7MG levels were not significantly different between the two experimental groups
at any time point (figure 3d). N-7MG was not detectable in control animals.  As N-
7MG removal was not affected by AGT activity, the concentration of N-7MG was
used to normalize the concentrations of O^MG and C^MT (figures 4a and b). The
normalized data suggests that while the disappearance of both 0''MG and O^MT is
affected by inhibition of AGT, the kinetics of removal are different for at least the
first 24 hours.  The calculated O'^MGiCMT ratio was -90:1 in the O'^BG treated
animals and -75:1 in the untreated animals at 12 hours, decreasing to -55:1 in the
treated animals and -15:1 in the untreated animals by 48 hours (figure 5).
DISCUSSION
This study demonstrates that the disappearzince of 0''MT in vivo is affected by
AGT.  By depleting AGT activity with O^BG prior to dosing with an alkylating agent,
SDMH, it was possible to study the removal of the resulting DNA adducts in the
absence of AGT repair. As expected, O^MG removal was inhibited by pretreatment
with O^BG.  However, this study also demonstrates that the removal of C'MT is
inhibited by pretreatment with the mammalian AGT inhibitor, O^BG.  Therefore,
removal of both of the promutagenic lesions, O^MG and 0'*MT, can be diminished by
inhibiting mammalian AGT activity.
Daily doses of O^BG were necessary to keep AGT activity diminished. It has been
shown previously that AGT activity can be inhibited by aUcyl adducts at the O^
position of guanine (Dolan 1990a, Dolan 1991).  O^BG has proven to be an efficient
inhibitor of AGT activity, probably due to the high affinity of AGT for benzyl groups
in a bimolecular substitution (Dolan 1990, Dolan 1991).  This study supports these
observations, as AGT activity was diminished below limits of detection through 48
hours in the animals dosed with O^BG daily. The animals that did not receive O^BG
were initially depleted for AGT activity due to saturation of this repair pathway by the
initial high amounts of O^MG induced by SDMH exposure.  As previously reported,
the exposure to SDMH induces the synthesis of AGT and therefore AGT activity
rebounds to higher activity in the group not dosed with O^BG (Bedell 1982, Pegg
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1983a, Singer 1986, Pegg 1987.)  Studies with human cells have shown that
pretreatment with O^BG results in an increase in cytotoxicity from
chloroethylnitrosourea chemotherapeutic agents (Dolan, 1990b).  This has clinical
application, in that O^BG administration may improve the efficacy of alkylating agents
by reducing AGT activity.
This study confirms the previously reported dependence of O^MG repair on AGT
(Pegg, 1981).  Whether AGT repair is saturated by high levels of alkylation by SDMH
or depleted by O^BG, O^MG was only slowly removed during the first 24 hours.  As
the AGT activity began to rise in the untreated animals, O^MG concentrations began
to decline.  O^MG repair under conditions of high O^MG concentrations in the non-
O^BG-treated population are consistent with previous reports of a tVi of -12 hours
(Herron 1981, Harbach 1982, Richardson  1985).   By 48 hours, when AGT activity
had risen above control levels, O^MG concentrations in this group had declined to
<10% of initial levels.
N-7MG, which is not subject to active repair by AGT, but is lost through
spontaneous depurination and DNA-7-methylguanine glycosylase activity, maintained
similar concentrations in both groups.  Therefore, N-7MG can be used as an internal
standard for alkylation in both the O^BG treated and untreated animals.  Margison et
al. has shown that glycosylase activity accounts for about twice the loss of N-7MG as
does chemical depurination (Margison, 1981).  The decrease in N-7MG levels agrees
with previous reports of a tVi of -47 hours in vivo (Becker 1981, Herron 1981).
Initially, following alkylation by SDMH, 0'*MT concentrations were stable in both
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the group with O^BG and without O^BG.   The calculated O^MG:0*MT ratios for the
animals not receiving O^BG were similar to previously reported values at 12 and 24
hours (Richardson, 1985).  As the activity of AGT returned to control levels and
above in the group not receiving O^BG, the amount of C^MT began to decline at a
rate similar to previous reports (tVi of -20 hours) (Richardson, 1985) .   In contrast,
the amount of CMT remained steady for 36 hours in the group treated with O^BG.
This suggests that AGT is involved in the disappearance of O^MT in vivo, as removal
was not apparent in animals in which AGT activity was reduced by 0*BG.
Although this study shows that the disappearance of 0'*MT is influenced by the
inhibition of AGT activity it can not show whether repair occurs through this pathway
alone, or whether there are additional factors.  The kinetics of removal appear to differ
between O^MG and O^MT under these conditions of inhibition and resynthesis of
AGT.    There are several possible explanations for this difference in response to AGT
inhibition.  One is that AGT has a stronger affinity for O^MG lesions than for C'MT
lesions.  Studies have been done on AGT proteins that show that E. coli ogt AGT has
a high affinity for 0*MT, while the E. coli ada gene product, human AGT, and yeast
AGT have a much lower affinity (Sassanfar, 1991).  If rodent AGT repairs 0'*MT, but
has a greater affinity for O^MG lesions, this could explain the delay in C^MT removal.
When AGT activity is low, binding is primarily to O^MG, providing a mechanism for
its preferential removal.   It is only when AGT activity increases that the 0'*MT
lesions, with their lower affinity, begin to disappear.  The affinity of human and yeast
AGT for O^MG is 20 and 30 times, respectively, higher than for O^MT (Sassanfar,
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1991).  Therefore, AGT affinity may be a controlling factor in the disappearance of
C'MT, even when AGT is abundant.  Richardson et al. have shown that during
continuous exposure to SDMH, 0'*MT and O^MG reach plateaus at nearly equal
concentrations, although O^MG is formed at nearly 100-fold greater concentrations
(Richardson, 1985).  This suggests that even when AGT is abundant (as in a chronic
exposure, when AGT activity is induced), O^MG is preferentially repaired over C'MT.
Also, removal of C'MT has been shown to plateau in vitro, using mammalian liver
extracts (Becker, 1985).  This may suggest that AGT repair of 0'*MT is site specific
and leads to persistant damage at a consensus sequence, as has been noted in the
repair of O^MG in E. coli (Topal 1986).  If this is true, this may explain why 0'*MT
repair was not apparent in in vitro studies using specific oligonucleotides (Dolan
1988).  It is also possible that binding to 0'*MT occurs, but that removal is impaired,
as has recently been suggested for O^-ethylguanine.  In studies using human cell lines,
Bronstein et al. (1992) have shown that excision repair cooperates with AGT repair to
remove 0*-ethylguanine adducts.  AGT may recognize and bind to O^EG sites on the
DNA, but only release the alkyl group slowly.  The bound protein is hypothesized to
act as a damage recognition signal for stimulating nucleotide excision repair (NER)
proteins to repair the lesion.  This mechanism is similar to the repair of thymine
dimers in DNA by the cooperative work of photolyase proteins and NER in E. coli
and Saccharomyces cerevisiae (Sancar, 1989).  Studies with E. coli have also linked
NER to repair of O^MG and O'EG (Samson 1988, Rossi 1989, Voigt 1991).
Investigations using AGT deficient and NER deficient human cell lines could
determine if the repair of CMT adducts is linked to these two pathways similar to
O^EG  in human cell lines and  E. coli, and O^MG in E. coli.  It is possible that
O^MT is bound by mammalian AGT, but also requires NER for removal.
In summary, AGT has been shown to be necessary for efficient C'MT removal,
although the repair kinetics differ from the repair of O^MG.  Further work that relates
the in vitro affinity studies to in vivo repair studies is necessary in order to better
understand the AGT repair system.
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Exhibit 1. HPLC separation of (a) O^MG, (b) N-7MG, (c) deoxynucleosides, and (d)
0*MT from DNA isolated from F344 rat livers, following exposure to SDMH and
O^BG.   Inset in (d) the results of the competitive RIA from the fractions collected
from the HPLC separation, showing correspondence to the known elution time of
0''MT, as determined by injection of visible standard onto the column.
Exhibit 2. Standard curve of competitive RIA for 0*MT (duplicate analysis), where b
= % inhibition of tracer from cold 0'*MT standards; logit b = In (b/lOO-b).
Exhibit 3. Depletion of (a) alkyltransferase activity, (b) O^MG, (c) O^'MT, and (d) N-
7MG in DNA isolated from F344 rat liver following exposure to SDMH and 0*BG.
Animals were sacrificed at the time points shown.  In all cases, squares represent
animals dosed with both O^BG and SDMH and diamonds represent animals dosed
with only SDMH. The means +/- SEM are shown for at least 3 animals analyzed in
duplicate.
Exhibit 4. Ratios of normalized data for (a) O'^MG and (b) CMT, using N-7MG to
normalize the data.  Squares represent animals dosed with both 0*'BG and SDMH and
diamonds represent animals dosed with only SDMH.
Exhibit 5. Normalized O^MG:0'*MT ratios in DNA isolated from F344 rat liver
following exposure to O^BG and SDMH.
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